Latest News about BIIB
Recent news which mentions BIIB
From Benzinga
Longer-Term Use, Early Initiation of Biogen's Experimental Drug For Inherited Rare Disease Slows Disease Progression
September 22, 2022
Tickers
BIIB
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2022
From Benzinga
Hurry! It’s Time to Take Your Profits From These 7 Stocks
September 13, 2022
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
September 13, 2022
From Benzinga
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
September 12, 2022
From InvestorPlace
This Stock Has Delivered a Gain of 100% Over the Past 3 Months. Can You Still Buy?
September 12, 2022
From Motley Fool
Has The Controversy Around Falsified Alzheimer's Research Impacted The Path To Finding The Cure?
September 07, 2022
From Benzinga
2 Top Biotech Stocks to Buy Right Now
September 04, 2022
From Motley Fool
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
August 26, 2022
From InvestorPlace
Why Axsome Therapeutics Stock Is Crushing It Today
August 19, 2022
From Motley Fool
Here's What Could Make This Beaten-Down Stock a Buy
August 19, 2022
From Motley Fool
7 F-Rated Stocks to Avoid Now
August 12, 2022
Tags
NASDAQ:BIIB,NYSE:CIM,NASDAQ:COIN,NYSE:DIS,NASDAQ:NFLX,NYSE:GPS,NASDAQ:IRBT,NASDAQ:PENN
PENN
GPS
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2022
From Benzinga
Is This Company In A Special Position Even As The COVID-19 Pandemic Affects Cell-Based Therapy Industry?
August 09, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
August 05, 2022
From Benzinga
7 Cheap Blue-Chip Stocks to Buy Before They Rebound
August 05, 2022
Tags
BRK/A
BIIB
NYSE:BAC,NYSE:MGM,NASDAQ:BIIB,NASDAQ:CSCO,NYSE:DIS,NYSE:GM,NASDAQ:MU,NYSE:BRK/A,NYSE:BRK/B
From InvestorPlace
From MarketWatch
Tickers
BIIB
From Motley Fool
Bill Gates, Jeff Bezos Unite To 'Change The Course' Of Neurological Disorder Impacting 6.5 Million Americans
July 30, 2022
From Benzinga
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
July 28, 2022
From Benzinga
From InvestorPlace
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.